These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9432529)

  • 61. Population-based assessments of clinical drug-drug interactions: qualitative indices or quantitative measures?
    Zhou H
    J Clin Pharmacol; 2006 Nov; 46(11):1268-89. PubMed ID: 17050792
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [General problems in the study of the mutagenic properties of drugs].
    Durnev AD; Volgareva GM; Seredenin SB
    Eksp Klin Farmakol; 1998; 61(2):4-12. PubMed ID: 9621164
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Drug-induced disorders.
    Friedman M
    Am Fam Physician; 1998 Jun; 57(11):2615-6. PubMed ID: 9636326
    [No Abstract]   [Full Text] [Related]  

  • 64. [Ensuring safe medication in the physician's office].
    Niebling W
    MMW Fortschr Med; 2006 May; 148(19):44-5. PubMed ID: 16736706
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Inappropriate drug use in the elderly: a nationwide register-based study.
    Johnell K; Fastbom J; Rosén M; Leimanis A
    Ann Pharmacother; 2007 Jul; 41(7):1243-8. PubMed ID: 17595305
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Avoiding adverse events.
    Carstairs E; McLaughlin S
    Br Dent J; 2007 Nov; 203(9):498. PubMed ID: 17992210
    [No Abstract]   [Full Text] [Related]  

  • 67. [Interactions in the family doctor's office: when pharmacotherapy itself becomes a problem].
    Stiefelhagen P
    MMW Fortschr Med; 2009 Jan; 151(3-4):38-41; quiz 42. PubMed ID: 19391398
    [No Abstract]   [Full Text] [Related]  

  • 68. [General principles of drug therapy in internal medicine].
    Komarov FI; Sumarokov AV
    Ter Arkh; 1983; 55(9):14-9. PubMed ID: 6635972
    [No Abstract]   [Full Text] [Related]  

  • 69. [How to identify and prevent pharmacokinetically relevant drug-drug interactions].
    Ritter CA
    Med Monatsschr Pharm; 2009 Oct; 32(10):364-74; quiz 375-6. PubMed ID: 19886226
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Trends in new drug interactions for pharmaceutical products in Japan.
    Yoshida N; Yamada A; Mimura Y; Kawakami J; Adachi I
    Pharmacoepidemiol Drug Saf; 2006 Jun; 15(6):421-7. PubMed ID: 16331581
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Potential interactions between prescription drugs and complementary and alternative medicines among patients in the emergency department.
    Taylor DM; Walsham N; Taylor SE; Wong L
    Pharmacotherapy; 2006 May; 26(5):634-40. PubMed ID: 16637793
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Adverse drug interactions in dentistry.
    Hersh EV; Moore PA
    Periodontol 2000; 2008; 46():109-42. PubMed ID: 18201348
    [No Abstract]   [Full Text] [Related]  

  • 73. [Adverse drug effect as cause of hospital admission. Common drugs are the major part according to the cross-sectional study].
    Odar-Cederlöf I; Oskarsson P; Ohlén G; Tesfa Y; Bergendal A; Helldén A; Bergman U
    Lakartidningen; 2008 Mar 18-Apr 1; 105(12-13):890-3. PubMed ID: 18461853
    [No Abstract]   [Full Text] [Related]  

  • 74. The growing issue of medication-related adverse events.
    Giaquinta D
    Manag Care Interface; 2007 Oct; 20(10):35-6. PubMed ID: 18405205
    [No Abstract]   [Full Text] [Related]  

  • 75. Clinical management of the dental patient taking multiple drugs.
    Jacobsen PL; Chávez EM
    J Contemp Dent Pract; 2005 Nov; 6(4):144-51. PubMed ID: 16299616
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Potential for drug interactions in hospitalized cancer patients.
    Riechelmann RP; Moreira F; Smaletz O; Saad ED
    Cancer Chemother Pharmacol; 2005 Sep; 56(3):286-90. PubMed ID: 15731916
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [The effect of drugs on the orofacial area].
    Vissink A; van Nieuw Amerongen A; Oremus ET
    Ned Tijdschr Tandheelkd; 1999 Jul; 106(7):254-63. PubMed ID: 11930371
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Enhanced funding of pharmacoepidemiology through patenting the disclosure of adverse event information.
    Classen JB
    Pharmacoepidemiol Drug Saf; 2006 Jun; 15(6):390-3. PubMed ID: 16411171
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Grapefruit-drug interactions: can interactions with drugs be avoided?
    Mertens-Talcott SU; Zadezensky I; De Castro WV; Derendorf H; Butterweck V
    J Clin Pharmacol; 2006 Dec; 46(12):1390-416. PubMed ID: 17101740
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Idiosyncratic drug reactions: past, present, and future.
    Uetrecht J
    Chem Res Toxicol; 2008 Jan; 21(1):84-92. PubMed ID: 18052104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.